- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05576350
TRAC-ER Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals (TRAC-ER)
Evaluation of a Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals
Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use. A mobile app has been developed that uses GPS tracking to determine when emerging adult sexual minority male and transgender (SMMTs) persons visit "risky" places and then delivers a survey asking what behaviors they engaged in while at the location.
The goal of the proposed study is to use this app to enhance the Tracking and Reducing Alcohol Consumption (TRAC) intervention by delivering messages that encourage participants to employ strategies discussed during TRAC sessions when arriving at risky places. When they leave these places, they will complete a survey and breathalyzer reading in order to collect event-level self-report and biological data on alcohol use and HIV risk. If their breathalyzer result indicates alcohol use, they will receive harm reduction messaging. It is expected that combining TRAC with EMI ("TRAC-ER") will increase effectiveness by reinforcing topics discussed during these sessions, providing in-the-moment messaging to address triggers, and collecting real-time alcohol use data.
Study Overview
Status
Conditions
Detailed Description
For this study, the investigators will enhance an existing mHealth intervention (TRAC) to reduce alcohol use among SMMT individuals by combining the intervention with an app which delivers EMI messages in real-time. Upon enrollment, participants will be randomized into one of 3 arms: TRAC-ER (EMI messaging, TRAC intervention, and smartphone-based alcohol monitoring), TRAC (TRAC intervention and smartphone-based alcohol monitoring), or a comparison group (smartphone-based alcohol monitoring only).
Participants will be recruited from Kentucky and Connecticut through community-based recruitment and health clinics that serve SMMT individuals.
Preliminary data used for this study were collected from a study (PI: Lauckner, K01AA02530) testing the TRAC intervention with people living with HIV/AIDS, which has shown promising preliminary results, with high feasibility, acceptability, and encouraging preliminary outcomes.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Carolyn Lauckner, PhD
- Phone Number: 859-562-3335
- Email: carolyn.lauckner@uky.edu
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University
-
Contact:
- Trace Kershaw, PhD
- Phone Number: 203-785-3441
- Email: trace.kershaw@yale.edu
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- University of Kentucky
-
Contact:
- Carolyn K Lauckner, PhD
- Phone Number: 859-562-3335
- Email: carolyn.lauckner@uky.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- self-identify as a sexual minority male (i.e., identifies as male and as a sexual orientation other than heterosexual) or as a transgender individual
- is between the ages of 18-35 at the start of the study
- owns a smartphone
- is HIV-negative (confirmed through a test at baseline)
- screens positively for at-risk alcohol use
- meets CDC PrEP eligibility criteria
Exclusion Criteria:
- do not speak English
- active psychosis or severe mental illness
- are actively detoxifying from substances and need medical supervision
- a score of 23 or greater on the Alcohol Withdrawal Symptom Checklist
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SAM-Only Comparison Group
Participants in this group will engage only in smartphone-based alcohol monitoring.
|
Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.
|
Experimental: TRAC plus SAM
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention and smartphone-based alcohol monitoring.
|
Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.
The TRAC intervention focuses on increasing motivation and building skills for avoiding triggers and managing situations that encourage drinking.
It requires four 30-minute sessions with a counselor using videoconferencing and mobile phones.
In addition to receiving the four sessions of intervention content, participants will complete smartphone-based self-monitoring of medication adherence and alcohol consumption, which will be discussed during intervention sessions.
|
Experimental: TRAC-ER plus SAM
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention combined with GPS-based ecological momentary interventions (EMI) and smartphone-based alcohol monitoring.
|
Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.
The TRAC intervention focuses on increasing motivation and building skills for avoiding triggers and managing situations that encourage drinking.
It requires four 30-minute sessions with a counselor using videoconferencing and mobile phones.
In addition to receiving the four sessions of intervention content, participants will complete smartphone-based self-monitoring of medication adherence and alcohol consumption, which will be discussed during intervention sessions.
Ecological momentary interventions (EMI) use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events.
GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of drinking days
Time Frame: 8 months (measured twice daily)
|
Number of days in which alcohol was consumed based on breathalyzer readings greater than 0.00
|
8 months (measured twice daily)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of binge drinking episodes
Time Frame: 8 months (measured daily)
|
Number of binge drinking episodes (occasions when participants had 5+ drinks based on self-reported number of drinks)
|
8 months (measured daily)
|
Number of drinks/drinking day
Time Frame: 8 months (measured daily)
|
Number of drinks per drinking day
|
8 months (measured daily)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol withdrawal
Time Frame: 8 months (measured daily)
|
Alcohol withdrawal symptom severity on a scale of 0-9, Alcohol Withdrawal Symptom Checklist
|
8 months (measured daily)
|
Hazardous/harmful drinking
Time Frame: 8 months
|
PROMIS SF Alcohol Use 7a, asks about hazardous/harmful drinking behaviors (e.g., drank too much, drank heavily).
Scores range from 7-35, higher scores mean more hazardous/harmful drinking behaviors.
|
8 months
|
Rate of alcohol use
Time Frame: 8 months
|
Number of self-reported drinking days reported via Timeline Followback
|
8 months
|
Alcohol cravings
Time Frame: 8 months
|
Individual thinking about alcohol and drinking behavior (Obsessive Compulsive Drinking Scale, scores ranging from 0-56; higher scores indicate higher rates of alcohol cravings)
|
8 months
|
Alcohol consequences
Time Frame: 8 months
|
Perceived negative consequences of using alcohol (e.g., unreliable, social problems, judgement; PROMIS SF Alcohol Use- Negative Consequences 7a). Scores range from 7-35; higher scores mean more perceived negative consequences. Perceived positive consequences of using alcohol (e.g., self-esteem, confidence, enjoyment; PROMIS SF Alcohol Use- Positive Consequences 7a). Scores range from 7-35; higher scores mean more perceived positive consequences. |
8 months
|
Alcohol expectancies
Time Frame: 8 months
|
Negative expectancies of alcohol use (e.g., making bad decisions, rudeness; PROMIS SF Alcohol Use- Negative Expectancies 7a). Scores range from 7-35; higher scores mean more negative expectancies. Positive expectancies of alcohol use (e.g., improves mood, improves sociability; PROMIS SF Alcohol Use- Positive Expectancies 7a). Scores range from 7-35; higher scores mean more positive expectancies. |
8 months
|
Readiness to change drinking
Time Frame: 8 months
|
Stage of change toward reducing alcohol use (precontemplation, contemplation, action)- Readiness to Change Questionnaire (scores ranging from -24 to +24; higher positive scores indicate a greater readiness to change drinking habits)
|
8 months
|
Drinking refusal self-efficacy
Time Frame: 8 months
|
Individuals' belief in their ability to resist alcohol (Drinking Refusal Self-Efficacy Questionnaire-R; 3 subscales: social pressure drinking, emotional relief drinking, opportunistic drinking.
Scores range from 0-114; higher scores indicate higher rates of refusal to drink.)
|
8 months
|
Condom attitudes
Time Frame: 8 months
|
Attitudes towards condoms across 7 factors: reliability and effectiveness, pleasure, identity stigma, embarrassment about purchase, negotiation, and action maintenance (Multidimensional Condom Attitudes Scale; scores range from 16-112; higher scores indicate more positive attitudes about condoms.)
|
8 months
|
Perceived HIV risk
Time Frame: 8 months
|
Likelihood estimates, intuitive judgements, and salience of HIV risk based on previous behaviors (Perceived Risk of HIV Scale).
Scores range from 10-40; higher scores indicate higher risk perception.
|
8 months
|
Discrimination due to sexual/gender identity
Time Frame: 8 months
|
Harassment, rejection, and family discrimination related to LGBTQ identities (Heterosexist Harassment, Rejection, and Discrimination Scale).
Scores range from 12-72; higher scores indicate more frequent occurrences of harassment/rejection/discrimination.
|
8 months
|
Sexual activity
Time Frame: 8 months (measured daily)
|
Engaged in sexual activity on previous day (percentage of respondents answering yes or no)
|
8 months (measured daily)
|
Characteristics of sex partners
Time Frame: 8 months (measured daily)
|
If applicable; number, type (percentage of respondents answering primary or non-primary partners), HIV status of partner(s) (percentage of respondents answering positive or negative status)
|
8 months (measured daily)
|
PrEP use
Time Frame: 8 months (measured daily)
|
Used PrEP on previous day (percentage of respondents answering yes or no)
|
8 months (measured daily)
|
Condomless sex
Time Frame: 8 months
|
If applicable; frequency of condomless sex for primary/non-primary partners assessed using a 5-point Likert scale ranging from "never" to "always"
|
8 months
|
Transactional sex
Time Frame: 8 months
|
Engagement in transactional sex (percentage of respondents answering yes or no)
|
8 months
|
Concurrent sex and substance use
Time Frame: 8 months
|
Engagement in concurrent sex and substance use (percentage of respondents answering yes or no)
|
8 months
|
Location characteristics - substances
Time Frame: 8 months (assessed up to 2x daily)
|
Substances used by participant at location (check all that apply from list if used yes/no; percentage of "yes" responses for each substance out of all location surveys completed by participant)
|
8 months (assessed up to 2x daily)
|
Location characteristics - sexual activity
Time Frame: 8 months (assessed up to 2x daily)
|
Sexual activity engaged in at location (yes/no; percentage of "yes" responses out of all location surveys completed by participant)
|
8 months (assessed up to 2x daily)
|
Location characteristics - harassment/discrimination
Time Frame: 8 months (assessed up to 2x daily)
|
Experienced harassment/discrimination at location (check all that apply from list: physical, emotional, or sexual harassment; percentage of "yes" responses for each type of harassment/discrimination out of all location surveys completed by participant)
|
8 months (assessed up to 2x daily)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Trace Kershaw, PhD, Yale University
- Principal Investigator: Carolyn Lauckner, PhD, University of Kentucky
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 79109
- 1R01AA030487-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Smartphone Based Alcohol Monitoring (SAM)
-
Federico II UniversityRecruitingHeart Failure | Sudden Cardiac Death | Cardiac ArrhythmiasItaly
-
Singapore General HospitalRootally AI PTE LTDNot yet recruiting
-
University of Wisconsin, MadisonCompletedSurgical Wound InfectionUnited States
-
Carnegie Mellon UniversityCompletedDietary Habits | Compliance BehaviorUnited States
-
The University of Hong KongRecruitingDepressive SymptomsHong Kong
-
Instituto Nacional de Ciencias Medicas y Nutricion...Conquer Cancer FoundationCompleted
-
Hanyang UniversityCompletedAppendix, UltrasonographyKorea, Republic of
-
University of ConnecticutNational Heart, Lung, and Blood Institute (NHLBI); Worcester Polytechnic InstituteCompleted
-
Wolfson Medical CenterCompletedPost Partum Depression | Breast Feeding, ExclusiveIsrael
-
The University of Hong KongCompletedTobacco Industry Denormalisation Beliefs | Tobacco-related CommunicationsHong Kong